LncRNA KCNA3 serves as a potential prognostic biomarker and therapeutic target for CRC since it inhibits the growth of tumors by downregulating the expression of YAP1 (Zhong et al. 2018). The gene discussed is YAP1; the disease is colorectal carcinoma.